Literature DB >> 31396352

Association of radiomic imaging features and gene expression profile as prognostic factors in pancreatic ductal adenocarcinoma.

Ke Li1, Jingjing Xiao2, Jiali Yang3, Meng Li2, Xuanqi Xiong1, Yongjian Nian4, Linbo Qiao5, Huaizhi Wang3, Aydin Eresen6, Zhuoli Zhang6, Xianling Hu1, Jian Wang1, Wei Chen1.   

Abstract

In this study, we investigated whether radiomic features of CT image data can accurately predict HMGA2 and C-MYC gene expression status and identify the patient survival time using a machine learning approach in pancreatic ductal adenocarcinoma (PDAC). A cohort of 111 patients with PDAC was enrolled in our study. Radiomic features were extracted using conventional (shape and texture analysis) and deep learning approaches following to segmentation of preoperative CT data. To predict patient survival time, significant radiomic features were identified using a log-rank test. After surgical resection, level of HMGA2 and C-MYC gene expressions of PDAC tumor regions were classified using a support vector machines method. The model was evaluated in terms of accuracy, sensitivity, specificity, and area under the curve (AUC). Besides, inter-reader reliability analysis was used to demonstrate the robustness of the proposed features. The identified features consistently achieved good performance in survival prediction and classification of gene expression status, on images segmented by different radiologists. Using CT data from 111 patients, six features in the segmented region of images were highly correlated with survival time. Using extracted deep features of excised lesions from 47 patients, we observed an average AUC score of 0.90 with an accuracy of 95% in C-MYC prediction (sensitivity: 92% and specificity: 98%). In HGMA2 group, using shape features, the average AUC score was measured as 0.91 with an accuracy of 88% (sensitivity: 89% and specificity: 88%). In conclusion, the radiomic features of CT image can accurately predict the expression status of HMGA2 and C-MYC genes and identify the survival time of PDAC patients.

Entities:  

Keywords:  Genomics; machine learning; pancreatic ductal adenocarcinoma; patient survival prediction; texture analysis

Year:  2019        PMID: 31396352      PMCID: PMC6684898     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  30 in total

1.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.

Authors:  Olivier Gevaert; Jiajing Xu; Chuong D Hoang; Ann N Leung; Yue Xu; Andrew Quon; Daniel L Rubin; Sandy Napel; Sylvia K Plevritis
Journal:  Radiology       Date:  2012-06-21       Impact factor: 11.105

2.  Another look at statistical learning theory and regularization.

Authors:  Vladimir Cherkassky; Yunqian Ma
Journal:  Neural Netw       Date:  2009-04-22

3.  Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy.

Authors:  Skye C Mayo; Marta M Gilson; Joseph M Herman; John L Cameron; Hari Nathan; Barish H Edil; Michael A Choti; Richard D Schulick; Christopher L Wolfgang; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2011-11-04       Impact factor: 6.113

4.  c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.

Authors:  C Schleger; C Verbeke; R Hildenbrand; H Zentgraf; U Bleyl
Journal:  Mod Pathol       Date:  2002-04       Impact factor: 7.842

Review 5.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

6.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

7.  Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival.

Authors:  Kenneth A Miles; Balaji Ganeshan; Matthew R Griffiths; Rupert C D Young; Christopher R Chatwin
Journal:  Radiology       Date:  2009-01-22       Impact factor: 11.105

Review 8.  c-Myc-induced genomic instability.

Authors:  Sabine Mai; J Frederic Mushinski
Journal:  J Environ Pathol Toxicol Oncol       Date:  2003       Impact factor: 3.567

9.  Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI.

Authors:  Ke Nie; Jeon-Hor Chen; Hon J Yu; Yong Chu; Orhan Nalcioglu; Min-Ying Su
Journal:  Acad Radiol       Date:  2008-12       Impact factor: 3.173

10.  Statistics review 12: survival analysis.

Authors:  Viv Bewick; Liz Cheek; Jonathan Ball
Journal:  Crit Care       Date:  2004-09-06       Impact factor: 9.097

View more
  8 in total

1.  Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.

Authors:  Emmanuel Salinas-Miranda; Gerard M Healy; Barbara Grünwald; Rahi Jain; Dominik Deniffel; Grainne M O'Kane; Robert Grant; Julie Wilson; Jennifer Knox; Steven Gallinger; Sandra Fischer; Rama Khokha; Masoom A Haider
Journal:  Eur Radiol       Date:  2022-08-25       Impact factor: 7.034

2.  Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

Authors:  Aydin Eresen; Kang Zhou; Chong Sun; Junjie Shangguan; Bin Wang; Liang Pan; Su Hu; Yongsheng Pang; Zigeng Zhang; Robert Minh Nhat Tran; Ajeet Pal Bhatia; Farouk Nouizi; Nadine Abi-Jaoudeh; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

3.  Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.

Authors:  Gerard M Healy; Emmanuel Salinas-Miranda; Rahi Jain; Xin Dong; Dominik Deniffel; Ayelet Borgida; Ali Hosni; David T Ryan; Nwabundo Njeze; Anne McGuire; Kevin C Conlon; Jonathan D Dodd; Edmund Ronan Ryan; Robert C Grant; Steven Gallinger; Masoom A Haider
Journal:  Eur Radiol       Date:  2021-11-10       Impact factor: 7.034

4.  Radiomics Model for Predicting TP53 Status Using CT and Machine Learning Approach in Laryngeal Squamous Cell Carcinoma.

Authors:  Ruxian Tian; Yumei Li; Chuanliang Jia; Yakui Mou; Haicheng Zhang; Xinxin Wu; Jingjing Li; Guohua Yu; Ning Mao; Xicheng Song
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 5.  Pancreas image mining: a systematic review of radiomics.

Authors:  Bassam M Abunahel; Beau Pontre; Haribalan Kumar; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-11-05       Impact factor: 5.315

Review 6.  Artificial intelligence for the management of pancreatic diseases.

Authors:  Myrte Gorris; Sanne A Hoogenboom; Michael B Wallace; Jeanin E van Hooft
Journal:  Dig Endosc       Date:  2020-12-05       Impact factor: 7.559

Review 7.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

8.  Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics.

Authors:  Jing Gao; Xiahan Chen; Xudong Li; Fei Miao; Weihuan Fang; Biao Li; Xiaohua Qian; Xiaozhu Lin
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.